Management of severe hyperkalemia

Critical Care Medicine

Volumn 36, Issue 12, 2008, Pages 3246-3251

  Weisberg, Lawrence S ^a  

^a Department of Anesthesiology   (United States)

Author keywords

Critical illness; Hyperkalemia; Treatment

Indexed keywords

ACETAZOLAMIDE; BICARBONATE; BUMETANIDE; CALCIUM CHLORIDE; FUROSEMIDE; GLUCONATE CALCIUM; GLUCOSE; INSULIN; KIONEX; LAXATIVE; POLYSTYRENESULFONATE SODIUM; POTASSIUM; SALBUTAMOL; SODIUM CHLORIDE; SORBITOL; TERBUTALINE; UNCLASSIFIED DRUG;

AMMONIA FORMATION; ASYSTOLE; BODY FLUID; CHRONIC DRUG ADMINISTRATION; CONSTIPATION; CONTINUOUS INFUSION; CRITICALLY ILL PATIENT; DEHYDRATION; DOSE RESPONSE; DRUG BINDING; DRUG EFFICACY; DRUG FATALITY; DRUG MEGADOSE; DRUG POTENTIATION; ECG ABNORMALITY; EMERGENCY TREATMENT; FLACCID PARALYSIS; HEART ARRHYTHMIA; HEART MUSCLE POTENTIAL; HEART VENTRICLE CONDUCTION; HEART VENTRICLE FIBRILLATION; HEMODIALYSIS; HEMODIALYSIS PATIENT; HOMEOSTASIS; HUMAN; HYPERCALCEMIA; HYPERKALEMIA; HYPOGLYCEMIA; HYPONATREMIA; INTESTINE NECROSIS; KALIURESIS; MEDLINE; METABOLIC ACIDOSIS; METABOLIC ALKALOSIS; PATHOPHYSIOLOGY; POTASSIUM EXCRETION; PRIORITY JOURNAL; REFLEX DISORDER; REPEATED DRUG DOSE; REVIEW; RISK ASSESSMENT; SIDE EFFECT; TACHYCARDIA; TISSUE NECROSIS; URINARY EXCRETION; METABOLISM;

HUMANS; HYPERKALEMIA; POTASSIUM;

EID: 58149241372     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e31818f222b     Document Type: Review

References (84)

1. Gennari FJ: Disorders of potassium homeostasis. Hypokalemia and hyperkalemia. Crit Care Clin 2002; 18:273-288, vi
2. Stevens MS, Dunlay RW: Hyperkalemia in hospitalized patients. Int Urol Nephrol 2000; 32:177-180
3. Ahmed J, Weisberg LS: Hyperkalemia in dialysis patients. Semin Dial 2001; 14:348-356
4. Clausen T, Everts ME: Regulation of the Na, K-pump in skeletal muscle. Kidney Int 1989; 35:1-13
5. DeFronzo RA, Felig P, Ferrannini E, et al: Effect of graded doses of insulin on splanchnic and peripheral potassium metabolism in man. Am J Physiol 1980; 238: E421-E427
6. DeFronzo RA, Bia M, Birkhead G: Epinephrine and potassium homeostasis. Kidney Int 1981; 20:83-91
7. Rosa RM, Silva P, Young JB, et al: Adrenergic modulation of extrarenal potassium disposal. N Engl J Med 1980; 302:431-434
8. Adrogue HJ, Madias NE: Changes in plasma potassium concentration during acute acid-base disturbances. Am J Med 1981; 71: 456-467
9. Magner PO, Robinson L, Halperin RM, et al: The plasma potassium concentration in metabolic acidosis: A re-evaluation. Am J Kidney Dis 1988; 11:220-224
10. Perez GO, Oster JR, Vaamonde CA: Serum potassium concentration in acidemic states. Nephron 1981; 27:233-243
11. Mount DB, Yu ASL: Transport of inorganic solutes: Sodium, chloride, potassium, magnesium, calcium and phosphorus. In: Brenner and Rector's The Kidney. Brenner B (Ed). Eighth Edition. Philadelphia, Saunders, 2007, pp 181-183
12. Velazquez H, Ellison DH, Wright FS: Luminal influences on potassium secretion: Chloride, sodium, and thiazide diuretics. Am J Physiol 1992; 262:F1076-F1082
13. Dunn MJ: Nonsteroidal antiinflammatory drugs and renal function. Annu Rev Med 1984; 35:411-428
14. Mathews A, Bailie GR: Acute renal failure and hyperkalemia associated with triamterene and indomethacin. Vet Hum Toxicol 1986; 28:224-225
15. Paladini G, Tonazzi C: Indomethacin-induced hyperkalemia and renal failure in multiple myeloma. Acta Haematol 1982; 68: 256-260
16. Juurlink DN, Mamdani MM, Lee DS, et al: Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study. N Engl J Med 2004; 351:543-551
17. Palmer BF: Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system. N Engl J Med 2004; 351: 585-592
18. Faridi AB, Weisberg LS: Acid-base, electrolyte and metabolic abnormalities. In: Critical Care Medicine: Principles of Diagnosis and Management in Adults. Parrillo JE, Dellinger RP (Eds). Third Edition. Philadelphia, Elsevier, 2008, pp 1203-1243
19. Fisch C: Relation of electrolyte disturbances to cardiac arrhythmias. Circulation 1973; 47: 408-419
20. Surawicz B: Electrolytes and the electrocar-diograim. Postgrad Med 1974; 55:123-129
21. Moore ML, Bailey RR: Hyperkalaemia in patients in hospital. N Z Med J 1989; 102: 557-558
22. Paice B, Gray JM, McBride D, et al: Hyperkalaemia in patients in hospital. Br Med J (Clin Res Ed) 1983; 286:1189-1192
23. Montague BT, Ouellette JR, Buller GK: Retrospective review of the frequency of ECG changes in hyperkalemia. Clin J Am Soc Nephrol 2008; 3:324-330
24. Szerlip HM, Weiss J, Singer I: Profound hyperkalemia without electrocardiographic manifestations. Am J Kidney Dis 1986; 7:461-465
25. Dodge HT, Grant RP, Seavey PW: The effect of induced hyperkalemia on the normal and abnormal electrocardiogram. Am Heart J 1953; 45:725-740
26. Weiner ID, Wingo CS: Hyperkalemia: A potential silent killer. J Am Soc Nephrol 1998; 9:1535-1543
27. Weiner M, Epstein FH: Signs and symptoms of electrolyte disorders. Yale J Biol Med 1970; 43:76-109
28. Tannen RL: Relationship of renal ammonia production and potassium homeostasis. Kidney Int 1977; 11:453-465
29. Szylman P, Better OS, Chaimowitz C, et al: Role of hyperkalemia in the metabolic acido-sis of isolated hypoaldosteronism. N Engl J Med 1976; 294:361-365
30. Weisberg LS: Potassium homeostasis. In: Principles and Practice of Medical Intensive Care. Carlson RW, Geheb MA (Eds). Philadelphia, Saunders, 1993
31. Bisogno JL, Langley A, Von Dreele MM: Effect of calcium to reverse the electrocardiographic effects of hyperkalemia in the isolated rat heart: A prospective, dose-response study. Crit Care Med 1994; 22:697-704
32. Chamberlain MJ: Emergency treatment of hyperkalaemia. Lancet 1964; 18:464-467
33. Ettinger PO, Regan TJ, Oldewurtel HA: Hyperkalemia, cardiac conduction, and the electrocardiogram: A review. Am Heart J 1974; 88:360-371
34. Semple P, Booth C: Calcium chloride; a reminder. Anaesthesia 1996; 51:93
35. Bower J, Mengle H: The additive effect of calcium and digitalis. A warning with a re- port of two deaths. JAMA 1936; 106: 1151-1153
36. Shrager MW: Digitalis intoxication; a review and report of forty cases, with emphasis on etiology. AMA Arch Intern Med 1957; 100: 881-893
37. Garcia-Palmieri MR: Reversal of hyperkalemic cardiotoxicity with hypertonic saline. Am Heart J 1962; 64:483-488
38. Ballantyne F III, Davis LD, Reynolds EW Jr, et al: Cellular basis for reversal of hyperkalemic electrocardiographic changes by sodium. Am J Physiol 1975; 229:935-940
39. Sterns RH, Feig PU, Pring M, et al: Disposition of intravenous potassium in anuric man: A kinetic analysis. Kidney Int 1979; 15: 651-660
40. Blumberg A, Weidmann P, Shaw S, et al: Effect of various therapeutic approaches on plasma potassium and major regulating factors in terminal renal failure. Am J Med 1988; 85:507-512
41. Lens XM, Montoliu J, Cases A, et al: Treatment of hyperkalaemia in renal failure: Salbutamol v. insulin. Nephrol Dial Transplant 1989; 4:228-232
42. Allon M, Copkney C: Albuterol and insulin for treatment of hyperkalemia in hemodialysis patients. Kidney Int 1990; 38:869-872
43. Allon M, Takeshian A, Shanklin N: Effect of insulin-plus-glucose infusion with or without epinephrine on fasting hyperkalemia. Kidney Int 1993; 43:212-217
44. Hundal HS, Marette A, Mitsumoto Y, et al: Insulin induces translocation of the alpha 2 and beta 1 subunits of the Na+/K(+)-ATPase from intracellular compartments to the plasma membrane in mammalian skeletal muscle. J Biol Chem 1992; 267:5040-5043
45. Minaker KL, Rowe JW: Potassium homeostasis during hyperinsulinemia: Effect of insulin level, beta-blockade, and age. Am J Physiol 1982; 242:E373-E377
46. Goldfarb S, Cox M, Singer I, et al: Acute hyperkalemia induced by hyperglycemia: Hormonal mechanisms. Ann Intern Med 1976; 84:426-432
47. Montoliu J, Lens XM, Revert L: Potassiumlowering effect of albuterol for hyperkalemia in renal failure. Arch Intern Med 1987; 147: 713-717
48. Allon M, Dunlay R, Copkney C: Nebulized albuterol for acute hyperkalemia in patients on hemodialysis. Ann Intern Med 1989; 110: 426-429
49. Montoliu J, Almirall J, Ponz E, et al: Treatment of hyperkalaemia in renal failure with salbutamol inhalation. J Intern Med 1990; 228:35-37
50. Nair S, Thomas E, Pearson SB, et al: A randomized controlled trial to assess the optimal dose and effect of nebulized albuterol in acute exacerbations of COPD. Chest 2005; 128:48-54
51. Mandelberg A, Krupnik Z, Houri S, et al: Salbutamol metered-dose inhaler with spacer for hyperkalemia: How fast? how safe? Chest 1999; 115:617-622
52. Sowinski KM, Cronin D, Mueller BA, et al: Subcutaneous terbutaline use in CKD to reduce potassium concentrations. Am J Kidney Dis 2005; 45:1040-1045
53. Fraley DS, Adler S: Correction of hyperkalemia by bicarbonate despite constant blood pH. Kidney Int 1977; 12:354-360
54. Allon M, Shanklin N: Effect of bicarbonate administration on plasma potassium in dialysis patients: Interactions with insulin and albuterol. Am J Kidney Dis 1996; 28:508-514
55. Gutierrez R, Schlessinger F, Oster JR, et al: Effect of Hypertonic versus isotonic sodiumbicarbonate on plasma potassium concentration in patients with end-stage renal-disease. Miner Electrolyte Metab 1991; 17:297-302
56. Kim HJ: Combined effect of bicarbonate and insulin with glucose in acute therapy of hyperkalemia in end-stage renal disease patients. Nephron 1996; 72:476-482
57. Blumberg A, Weidmann P, Ferrari P: Effect of prolonged bicarbonate administration on plasma potassium in terminal renal failure. Kidney Int 1992; 41:369-374
58. Carlisle EJ, Donnelly SM, Ethier JH, et al: Modulation of the secretion of potassium by accompanying anions in humans. Kidney Int 1991; 39:1206-1212
59. Kamel KS, Ethier JH, Quaggin S, et al: Studies to determine the basis for hyperkalemia in recipients of a renal transplant who are treated with cyclosporine. J Am Soc Nephrol 1992; 2:1279-1284
60. Scherr L, Ogden DA, Mead AW, et al: Management of hyperkalemia with a cationexchange resin. N Engl J Med 1961; 264: 115-119
61. Frohnert PP, Johnson WJ, Mueller GJ, et al: Resin treatment of hyperkalemia. II. Clinical experience with a cation exchange resin (calcium cycle). J Lab Clin Med 1968; 71: 840-846
62. Frohnert PP, Johnson WJ, Mueller GJ, et al: Resin treatment of hyperkalemia. I. Exchange properties of a cation exchange resin (calcium cycle). J Lab Clin Med 1968; 71: 834-839
63. Lillemoe KD, Romolo JL, Hamilton SR, et al: Intestinal necrosis due to sodium polystyrene (Kayexalate) in sorbitol enemas: Clinical and experimental support for the hypothesis. Surgery 1987; 101:267-272
64. Gruy-Kapral C, Emmet M, Santa Nan CA, et al: Effect of single dose resin-cathartic therapy on serum potassium concentration in patients with end-stage renal disease. J Am Soc Nephrol 1998; 9:1924-1930
65. Rogers FB, Li SC: Acute colonic necrosis associated with sodium polystyrene sulfonate (Kayexalate) enemas in a critically ill patient: Case report and review of the literature. J Trauma 2001; 51:395-397
66. Rashid A, Hamilton SR: Necrosis of the gastrointestinal tract in uremic patients as a result of sodium polystyrene sulfonate (kayexalate) in sorbitol: An underrecognized condition. Am J Surg Pathol 1997; 21:60-69
67. Scott TR, Graham SM, Schweitzer EJ, et al: Colonic necrosis following sodium polystyrene sulfonate (kayexalate)-sorbitol enema in a renal transplant patient. Report of a case and review of the literature. Dis Colon Rectum 1993; 36:607-609
68. Wootton FT, Rhodes DF, Lee WM, et al: Colonic necrosis with kayexalate-sorbitol enemas after renal transplantation. Ann Intern Med 1989; 111:947-949
69. Chatelain D, Brevet M, Manaouil D, et al: Rectal stenosis caused by foreign body reaction to sodium polystyrene sulfonate crystals (kayexalate). Ann Diagn Pathol 2007; 11: 217-219
70. Abraham SC, Bhagavan BS, Lee LA, et al: Upper gastrointestinal tract injury in patients receiving kayexalate (sodium polystyrene sulfonate) in sorbitol: Clinical, endoscopic, and histopathologic findings. Am J Surg Pathol 2001; 25:637-644
71. Cheng ES, Stringer KM, Pegg SP: Colonic necrosis and perforation following oral sodium polystyrene sulfonate (resonium A/kayexalate in a burn patient. Burns 2002; 28:189-190
72. Dardik A, Moesinger RC, Efron G, et al: Acute abdomen with colonic necrosis induced by kayexalate-sorbitol. South Med J 2000; 93: 511-513
73. Gardiner GW: Kayexalate (sodium polystyrene sulphonate) in sorbitol associated with intestinal necrosis in uremic patients. Can J Gastroenterol 1997; 11:573-577
74. Roy-Chaudhury P, Meisels IS, Freedman S, et al: Combined gastric and ileocecal toxicity (serpiginous ulcers) after oral kayexalate in sorbital therapy. Am J Kidney Dis 1997; 30: 120-122
75. Gerstman BB, Kirkman R, Platt R: Intestinal necrosis associated with postoperative orally administered sodium polystyrene sulfonate in sorbitol. Am J Kidney Dis 1992; 20: 159-161
76. Blumberg A, Roser HW, Zehnder C, et al: Plasma potassium in patients with terminal renal failure during and after haemodialysis; relationship with dialytic potassium removal and total body potassium. Nephrol Dial Transplant 1997; 12:1629-1634
77. Zehnder C, Gutzwiller JP, Huber A, et al: Low-potassium and glucose-free dialysis maintains urea but enhances potassium removal. Nephrol Dial Transplant 2001; 16: 78-84
78. Hou S, McElroy PA, Nootens J, et al: Safety and efficacy of low-potassium dialysate. Am J Kidney Dis 1989; 13:137-143
79. Karnik JA, Young BS, Lew NL, et al: Cardiac arrest and sudden death in dialysis units. Kidney Int 2001; 60:350-357
80. Kovesdy CP, Regidor DL, Mehrotra R, et al: Serum and dialysate potassium concentrations and survival in hemodialysis patients. Clin J Am Soc Nephrol 2007; 2:999-1007
81. Lafrance JP, Nolin L, Senecal L, et al: Predictors and outcome of cardiopulmonary resuscitation (CPR) calls in a large haemodialysis unit over a seven-year period. Nephrol Dial Transplant 2006; 21:1006-1012
82. Morrison G, Michelson EL, Brown S, et al: Mechanism and prevention of cardiac arrhythmias in chronic hemodialysis patients. Kidney Int 1980; 17:811-819
83. Redaelli B, Locatelli F, Limido D, et al: Effect of a new model of hemodialysis potassium removal on the control of ventricular arrhythmias. Kidney Int 1996; 50: 609-617
84. Sforzini S, Latini R, Mingardi G, et al: Ventricular arrhythmias and four-year mortality in haemodialysis patients. Gruppo Emodialisi e Patologie Cardiovascolari. Lancet 1992; 339:212-213